WBZ-TV's Tiffany Chan reports.
When this nurse first experienced pain in her side, doctors didn't notice anything. A year later, it returned — and new imaging found nodules in her lung that were cancerous.
- The Courier Journal
Testing, masking, avoiding indoor crowded settings and keeping vaccinations and boosters up to date are the best strategies we have to stay safe
The study’s findings may eventually lead to the development of probiotics specifically for people who come down with COVID.
- USA TODAY Sports - Golfweek
Talk among athletes and the orthopedic community is that there is more plantar fasciitis than there used to be.
- Fox News
Patrick Swayze’s widow reflects on finding love again: ‘Just because you lose someone doesn’t mean love stops’
Patrick Swayze, the husband of Lisa Niemi Swayze who starred in "Dirty Dancing” and Ghost," passed away in 2009 from advanced pancreatic cancer. He was 57.
- Yahoo News
The coronavirus has continued to mutate, and two new Omicron subvariants have become dominant in the U.S., according to the CDC. The subvariants, called BQ.1 and BQ.1.1, now account for more than half of infections nationwide.
- Eating Well
Find out why, and how to stress less and protect your heart health.
- The Star Press
It's been found that an average of 80-90% of lung cancer related deaths are related to smoking.
- Erie Times News
This surge in COVID-19 deaths is far different from the ones the county experienced in late 2020 and 2021, which killed hundreds of people each year.
- Good Morning America
A New York mother is sharing details of her daughter's battle with RSV, a respiratory virus that health officials warn may continue to spread this holiday season, along with the flu and COVID-19. Anita Binayi-Ghiam said her 3-year-old daughter Ella began having difficulty breathing during the last week of October.
- The Hill
Correction: Approximately 2,900 Americans have died from the flu so far this season. The data was incorrect in an earlier version of this story. Flu season is intensifying in the U.S. with more than 6 million cases confirmed so far, the Centers for Disease Control and Prevention (CDC) reported on Monday. The federal health agency…
Multiple teams are studying the drug's effects on chronic Long COVID symptoms such as fatigue and brain fog.
- Dr. Phil CBS
Every year, more than a million people are diagnosed with type 2 diabetes, and one out of every 10 Americans has type 2 diabetes. “Diabetes is bad. It’s the leading cause of blindness. It increases heart disease risk,” says Dr. John Whyte. “It really needs to be taken seriously.” Dr. Whyte, Chief Medical Officer at WebMD and author of Take Control of Your Diabetes Risk, joins Dr. Phil on Tuesday’s episode and offers tips for taking control of your health. In the video above, hear why he says diabetes needs to be taken seriously, and he busts myths surrounding the disease. Tune in to Tuesday's episode, “Procreation Debate: Is it Smart to Have Children?” to find out one of the most important ways to combat diabetes. Check local listings to see where you can watch.
- ABC News Videos
ABC News chief medical correspondent Dr. Jen Ashton talks through some of the symptoms outside of chest pain that could be a sign of a heart attack.
- Women's Health
Injectable medications Ozempic and Wegovy have gone viral thanks to its weight loss benefits. Here's what to know about semaglutide and its side effects.
- BuzzFeed News
Amoxicillin Is In Short Supply. Here’s What To Know About The Liquid Antibiotic That’s Commonly Used To Treat Kids.
The shortage of this liquid antibiotic, which is often the first-choice treatment for children’s ear infections and other problems, is expected to last several months.View Entire Post ›
A Japanese biotech firm says it has developed the world's first early screening test for pancreatic cancer, using the powerful noses of tiny worms. Hirotsu Bio Science this month launched its N-NOSE plus Pancreas test, marketing directly to consumers in Japan and with aims to bring the test to the United States by 2023. Users send a urine sample through a special mail pouch to a lab, where it is put in a petri dish with a species of nematodes.
CHICAGO (Reuters) -The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-robbing disease, according to interviews with researchers and pharmaceutical executives. The finding validates the theory that clearing the amyloid protein that forms clumps in the brains of Alzheimer’s patients could slow or halt the disease and has strengthened the support from some scientists for simultaneously targeting another notorious protein linked to Alzheimer's: tau. Eisai and Biogen are scheduled to present full data from their lecanemab study on Tuesday at the Clinical Trials on Alzheimer's Disease conference in San Francisco.
- ABC News Videos
There have been nearly 3,000 flu-related deaths since October with the Centers for Disease Control and Prevention saying deaths are at their highest rate in 10 years for this time of year.
- Associated Press
Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better treatments of the incurable disease. The data was presented at an Alzheimer’s meeting in San Francisco and published in The New England Journal of Medicine. Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study, Eisai’s Dr. Michael Irizarry told The Associated Press.